Identification of Tumor-Specific Antibodies in Patients With Breast Cancer Vaccinated With Gene-Modified Allogeneic Tumor Cells

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

2001 • 11,070 citations

Tumor Rejection After Direct Costimulation of CD8 ⁺ T Cells by B7-Transfected Melanoma Cells

1993 • 1,154 citations

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

1992 • 1,076 citations

Breast Tumor Cell Lines From Pleural Effusions2

1974 • 973 citations

Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside.

1994 • 522 citations

Prolongation of Survival in Metastatic Melanoma After Active Specific Immunotherapy With a New Polyvalent Melanoma Vaccine

1992 • 410 citations

Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer.

1999 • 300 citations

Development of Antibodies to Fetal Calf Serum With Arthus-Like Reactions in Human Immunodeficiency Virus–Infected Patients Given Syngeneic Lymphocyte Infusions

1997 • 268 citations

Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma.

1992 • 261 citations

Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells

2000 • 234 citations

Survival in Early Breast Cancer Patients Is Favorably Influenced by a Natural Humoral Immune Response to Polymorphic Epithelial Mucin

2000 • 224 citations

Immunobiology of primary intracranial tumors

1977 • 191 citations

Correlation of specific immune responses with survival in melanoma patients with distant metastases receiving polyvalent melanoma cell vaccine.

1998 • 162 citations

Pre-existent immunity to the HER-2/neu oncogenic protein in patients with HER-2/neu overexpressing breast and ovarian cancer

2000 • 161 citations

Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo?

1996 • 147 citations

Specificity and longevity of antitumor immune responses induced by B7-transfected tumors.

1994 • 141 citations

A phase I clinical trial of immunotherapy with interferon-? gene-modified autologous melanoma cells

1997 • 108 citations

Antibody immunity to the HER-2/neu oncogenic protein in patients with colorectal cancer

1999 • 68 citations

Heterologous Sera: A Target for in Vitro Cell-Mediated Cytotoxicity

1976 • 68 citations

An Enzyme-Linked Immunosorbent Assay for the Measurement of Circulating Antibodies to Polymorphic Epithelial Mucin (MUC1)

1998 • 67 citations

Establishing In Vitro Cultures of Autologous Tumor Cells for Use in Active Specific Immunotherapy

1993 • 64 citations

Rituximab in the treatment of diffuse large B-cell lymphomas

2002 • 62 citations

Anaphylaxis to infusion of autologous bone marrow: An apparent reaction to self, mediated by IgE antibody to bovine serum albumin

1989 • 38 citations

Allergenic and antigenic properties of bovine serum albumin

1981 • 38 citations

Trastuzumab in combination with chemotherapy for the treatment of metastatic breast cancer.

2000 • 38 citations

The serologic response of patients with stage II melanoma to allogeneic melanoma cell vaccines

1985 • 33 citations

A Phase I Trial of B7-Transfected or Parental Lethally Irradiated Allogeneic Melanoma Cell Lines to Induce Cell-Mediated Immunity Against Tumor-Associated Antigen Presented by HLA-A2 or HLA-A1 in Patients with Stage IV Melanoma. National Institutes of Health, Bethesda, Maryland

1995 • 33 citations

Immunobiology of primary intracranial tumors

1983 • 27 citations

Circulating anti-CEA antibodies in the sera of patientswith breast cancer

2000 • 26 citations

Specific cytotoxic lymphocytes against syngeneic tumors are generated in culture in the presence of syngeneic, but not xenogeneic, serum

1978 • 21 citations

Humoral immune response to intralymphatic immunotherapy for disseminated melanoma: correlation with clinical response.

1982 • 20 citations

A serologic study of cultured breast cancer cell lines: lack of antibody response to tumour specific membrane antigens in patients.

1980 • 13 citations

B7-1 gene-modified tumor cell vaccines.

1999 • 13 citations